Winway Health Desk
Who were biopharma’s Q4 growth stars? Vertex, thanks to a new...
Several of the industry's top players turned in a strong performance in the fourth quarter, growing revenues at high single-digit rates, an analysis shows. Others?...
Esperion notches 2nd FDA approval with cholesterol-lowering combo Nexlizet
Esperion, aiming to reconfigure the cholesterol-lowering market, notched its first FDA approval last week for a novel drug expected to hit shelves at a...
New CDMO allows Acacia Pharma to win FDA approval of nausea...
Popular logic says you never switch horses, or CDMOs, in the middle of the stream. Biotch Acacia Pharma had to do just that to...
Fujifilm Diosynth Biotechnologies expansion to add cell and microbial capacity
Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects, a $55...
Lilly’s Cyramza wins narrow thumbs-up from FDA advisers for Tarceva combo...
In a less-than-ringing endorsement, FDA advisers voted Wednesday 6-5 in favor of approving Eli Lilly’s Cyramza plus Roche’s Tarceva in previously untreated EGFR-positive non-small...
Pfizer, Mylan vets tapped for Viatris board, C-suite as merger nears
With the board appointments of former leaders at Pfizer and Mylan, generics megamerger Viatris has already indicated its predecessors would play an outsized leadership role....
Sandoz pledges ‘stable’ pricing for generics, antibiotics amid COVID-19 supply chain...
COVID-19's global spread has raised fears over drug shortages and price spikes, but Novartis' Sandoz is taking an early step to allay those concerns. The drugmaker, a top player in...
Here are the leading companies enlisting in the fight against coronavirus
A healthcare worker tests a woman’s temperature at a hospital in Turin, Italy. Northern Italy’s Lombardy region has seen a large outbreak of the...
Symptom checker K Health raises $48M
K Health, a startup that lets patients look up their symptoms and chat with a doctor, closed a $48 million series C round. 14W...
Fresh off its first FDA approval, Esperion gets green light for...
Just days after it received approval for its non-statin drug for lowering cholesterol, Esperion Therapeutics has won approval for its second product.
The Food and...
